2021
DOI: 10.1111/cxo.13128
|View full text |Cite
|
Sign up to set email alerts
|

Comparisons of atropine versus cyclopentolate cycloplegia in myopic children

Abstract: Clinical relevance: In clinical practice, 1% atropine and 1% cyclopentolate are used as cycloplegia agents to diagnose refractive error. The influence of 1% atropine on ocular biometry is obscure, and the impact of 1% cyclopentolate remains controversial. Background: This study aims to compare the effects of atropine versus cyclopentolate cycloplegia on ocular biometry in myopic children and to determine the sites of action for atropine. Methods: A total of 207 myopic children aged 6-12-years were included in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
28
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 26 publications
(32 citation statements)
references
References 37 publications
(45 reference statements)
4
28
0
Order By: Relevance
“…Although the changes in AL were not significant compared with baseline at 1 week, the decrease in AL was observed. This trend was consistent with the findings of Ye et al (2021 ). These findings suggest that the improved effect of 0.01% atropine eye drop instillation on SE might be affected by the shortened AL.…”
Section: Discussionsupporting
confidence: 93%
“…Although the changes in AL were not significant compared with baseline at 1 week, the decrease in AL was observed. This trend was consistent with the findings of Ye et al (2021 ). These findings suggest that the improved effect of 0.01% atropine eye drop instillation on SE might be affected by the shortened AL.…”
Section: Discussionsupporting
confidence: 93%
“…The study design has been previously described. 30 In brief, 207 children aged 6 to 12 years with myopic refraction of at least −0.5 diopter (D) and astigmatism of less than −2.0 D in both eyes were enrolled in this randomized clinical trial. After excluding those with ocular diseases or severe systemic diseases, previous use of myopia interventions (such as atropine, pirenzepine, or orthokeratology lens), or allergy to atropine and cyclopentolate, children were randomly assigned to one of two groups in a ratio of 1:1: group A received 1% atropine (Dishan, Shenyang Xingqi Pharmaceutical Co., LTD., Shenyang, China), and group B received 0.01% atropine (Myopine, Shenyang Xingqi Eye Hospital Co., LTD., Shenyang, China), in both eyes.…”
Section: Methodsmentioning
confidence: 99%
“…Examination procedures were performed as previously described. 30 Briefly, each participant underwent a series of ophthalmic examinations, including measurement of intraocular pressure using a noncontact tonometry (NT-1000; Nidek, Tokyo, Japan), pupil size using an IOL-Master 700 (Carl Zeiss Meditec AG, Jena, Germany), best-corrected distance VA in the logMAR, near VA under best-corrected distance spectacle correction at 40 cm, and near point of accommodation with best-corrected distance spectacle correction. The accommodation amplitude was calculated as the inverse of the near point of accommodation.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…After 2 consecutive weeks of dropwise administration of 1% atropine, the paralysis of the ciliary muscles was more complete. 15,16 When paralyzed, the ciliary muscles are relaxed, which leads to the tight pulling of the suspensory ligaments, the thinning of the lens, the shortening of the ocular axis, and a decrease in spherical equivalent. 17 This suggests that the sphere and ocular axial length of the treatment group in that study had already been significantly reduced at baseline.…”
Section: Comparison Of Longitudinal Studiesmentioning
confidence: 99%